Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy.
Chen M, Liu X, Peng N, Zhang T, Mou J, He H, Wang Y, Xu Y, Xing H, Tang K, Tian Z, Rao Q, Gu R, Qiu S, Wang M, Wang J.
Chen M, et al. Among authors: wang j, wang y, wang m.
Exp Hematol Oncol. 2023 Jul 24;12(1):64. doi: 10.1186/s40164-023-00423-0.
Exp Hematol Oncol. 2023.
PMID: 37488603
Free PMC article.